JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0%
Tue, 21 May

JUBILANT LIFE SCIENCES has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

JUBILANT LIFE SCIENCES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m22,52023,77123,8560.4%5.9%
Other incomeRs m22929066-77.3%-71.3%
TurnoverRs m22,74924,06123,922-0.6%5.2%
ExpensesRs m17,94118,83820,2767.6%13.0%
Gross profitRs m4,5794,9331,101-77.7%-76.0%
DepreciationRs m1,817984950-3.4%-47.7%
InterestRs m725683616-9.8%-15.0%
Profit before taxRs m2,2663,556-400-111.2%-117.6%
TaxRs m742881607-31.1%-18.2%
Profit after taxRs m1,5242,675-1,007-137.6%-166.0%
Gross profit margin%20.320.84.6
Effective tax rate%32.724.8-151.8
Net profit margin%6.711.1-4.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 5.9% on a year-on-year (YoY) basis. The expenses were up by 13.0% YoY during the same period.
  • The company's operating profit declined by 76.0% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 4.6% in 4QFY19 as against 20.3% in 4QFY18.
  • Depreciation charges declined by 47.7% and finance costs declined by 15.0% YoY, respectively.
  • Other income declined by 71.3% YoY during the quarter.
  • Net profit for the quarter declined by 166.0% YoY. Net profit margins during the quarter declined from 6.7% in 4QFY18 to -4.2% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 7.6% QoQ during the same period.
  • The company's operating profit declined by 77.7% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 4.6% in 4QFY19 as against 20.8% in 3QFY18.
  • Net profit for the quarter declined by 137.6% QoQ, while net profit margins declined from 11.1% in 3QFY18 to -4.2% in 4QFY19.

To see how JUBILANT LIFE SCIENCES has performed over the last eight quarters, please visit here.

JUBILANT LIFE SCIENCES Share Price Performance

Over the last one year, JUBILANT LIFE SCIENCES share price has moved up from Rs 780.1 to Rs 581.0, registering a Loss of Rs 199.1 or around 25.5%.

Meanwhile, the S&P BSE OIL & GAS Index is trading at Rs 15,220.5 (down 0.5%). Over the last one year it has moved up from 14,313.4 to 15,220.5, a gain of 907 points (up 6.3%).

Overall, the S&P BSE SENSEX is up 13.9% over the year.

Current Valuations

At the current price of Rs 581.0, the price to earnings (P/E) ratio of JUBILANT LIFE SCIENCES stands at 16.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.3 times.

Equitymaster requests your view! Post a comment on "JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0%". Click here!

  

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Mar 31, 2020 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - ACTAVIS COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS